tradingkey.logo

Clarivate PLC

CLVT
2.160USD
+0.070+3.37%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
1.43BCap. mercado
PérdidaP/E TTM

Más Datos de Clarivate PLC Compañía

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

Información de Clarivate PLC

Símbolo de cotizaciónCLVT
Nombre de la empresaClarivate PLC
Fecha de salida a bolsaOct 29, 2018
Director ejecutivoTov (Matitiahu Shem)
Número de empleados12000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
Dirección70 St. Mary Axe
CiudadLONDON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited Kingdom
Código postalEC3A 8BE
Teléfono442074334000
Sitio Webhttps://clarivate.com/
Símbolo de cotizaciónCLVT
Fecha de salida a bolsaOct 29, 2018
Director ejecutivoTov (Matitiahu Shem)

Ejecutivos de Clarivate PLC

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
419.24K
-309902.00%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
341.06K
-70746.00%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
299.94K
-189032.00%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+34499.00%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+29976.00%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+33431.00%
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
36.67K
+3963.00%
Mr. Anthony Munk
Mr. Anthony Munk
Lead Independent Director
Lead Independent Director
--
--
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
419.24K
-309902.00%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
341.06K
-70746.00%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
299.94K
-189032.00%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+34499.00%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+29976.00%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+33431.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Subscription revenues
405.40M
65.06%
Transactional revenues
112.40M
18.04%
Re-occurring revenues
105.30M
16.90%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
331.30M
53.17%
Europe/ Middle East /Africa
168.30M
27.01%
Asia Pacific
123.50M
19.82%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Subscription revenues
405.40M
65.06%
Transactional revenues
112.40M
18.04%
Re-occurring revenues
105.30M
16.90%

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Leonard Green & Partners, L.P.
17.64%
Giovanni Agnelli B V
10.17%
Clarkston Capital Partners, LLC
10.09%
Onex Corporation
6.34%
Selige Co-Investor Pooling SCSp
5.76%
Otro
50.01%
Accionistas
Accionistas
Proporción
Leonard Green & Partners, L.P.
17.64%
Giovanni Agnelli B V
10.17%
Clarkston Capital Partners, LLC
10.09%
Onex Corporation
6.34%
Selige Co-Investor Pooling SCSp
5.76%
Otro
50.01%
Tipos de accionistas
Accionistas
Proporción
Private Equity
31.46%
Investment Advisor
29.12%
Hedge Fund
12.19%
Holding Company
10.17%
Investment Advisor/Hedge Fund
9.22%
Corporation
5.76%
Pension Fund
1.77%
Research Firm
1.05%
Individual Investor
1.04%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
535
592.98M
105.89%
+6.90K
2025Q3
602
592.98M
107.55%
-12.23M
2025Q2
641
615.33M
113.09%
-20.61M
2025Q1
673
634.58M
117.94%
-171.09M
2024Q4
687
649.99M
118.14%
-11.56M
2024Q3
702
655.24M
113.94%
+3.30M
2024Q2
715
650.43M
105.77%
+33.49M
2024Q1
726
617.29M
113.75%
-142.82M
2023Q4
754
617.55M
121.55%
-46.09M
2023Q3
759
661.45M
111.82%
+27.54M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Leonard Green & Partners, L.P.
116.67M
17.64%
--
--
Sep 30, 2025
Giovanni Agnelli B V
67.29M
10.17%
--
--
Sep 30, 2025
Clarkston Capital Partners, LLC
66.71M
10.09%
-3.32M
-4.74%
Sep 30, 2025
Onex Corporation
41.92M
6.34%
-938.25K
-2.19%
Mar 10, 2025
Selige Co-Investor Pooling SCSp
38.09M
5.76%
--
--
Mar 10, 2025
Partners Group AG
25.58M
3.87%
--
--
Sep 30, 2025
Fidelity Investments Canada ULC
24.70M
3.73%
+7.82M
+46.36%
Sep 30, 2025
Cambridge Information Group, Inc.
23.90M
3.61%
+290.94K
+1.23%
Mar 10, 2025
Impactive Capital LP
43.03M
6.5%
--
--
Sep 30, 2025
Dimensional Fund Advisors, L.P.
21.77M
3.29%
+696.90K
+3.31%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Technology Alphadex
1.17%
Avantis US Small Cap Value ETF
0.16%
WisdomTree US MidCap Fund
0.14%
DFA Dimensional US Small Cap Value ETF
0.13%
JPMorgan US Value Factor ETF
0.13%
Nuveen ESG Small-Cap ETF
0.09%
John Hancock Multifactor Small Cap ETF
0.09%
Avantis US Small Cap Equity ETF
0.08%
Invesco RAFI US 1500 Small-Mid ETF
0.08%
BNY Mellon US Small Cap Core Equity ETF
0.07%
Ver más
First Trust Technology Alphadex
Proporción1.17%
Avantis US Small Cap Value ETF
Proporción0.16%
WisdomTree US MidCap Fund
Proporción0.14%
DFA Dimensional US Small Cap Value ETF
Proporción0.13%
JPMorgan US Value Factor ETF
Proporción0.13%
Nuveen ESG Small-Cap ETF
Proporción0.09%
John Hancock Multifactor Small Cap ETF
Proporción0.09%
Avantis US Small Cap Equity ETF
Proporción0.08%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.08%
BNY Mellon US Small Cap Core Equity ETF
Proporción0.07%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI